Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet studyDaniela Cilloni, Aline Renneville, Fabienne Hermitte, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Haematologica|May 28, 2016
A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agentsSylvain Thépot, Raouf Ben Abdelali, Sylvie Chevret, et al.
Hemasphere|June 17, 2026
Mutational dynamics in patients with del(5q) MDS treated with lenalidomide prior to transfusion dependency-Molecular results from the Sintrarev clinical trialSofía Toribio Castelló, Felix López-Cadenas, Claude Preudhomme, et al.
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
Blood Cancer Journal|June 24, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, et al.
Blood Advances|May 8, 2020
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study resultsClaude Gardin, Cécile Pautas, Elise Fournier, et al.
Cell Reports|January 23, 2020
Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone MarrowEtienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, et al.
Blood Advances|October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availabilityMarie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
Pageof 22